• Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II 


    • Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company 


    • VelosBio Agrees to Sell to Merck for $2.75 Billion 


    • Forbius Agrees to Sell to Bristol Myers Squibb 


    • Forty Seven Agrees to Sell to Gilead for $4.9 Billion  


    • Synthorx to Sell to Sanofi for $2.5 Billion